Though Ozempic became famous as a Hollywood weight-loss drug, for millions of Americans, Ozempic is a much-needed treatment for diabetes, obesity, and has shown promising effects in preventing Alzheimer’s. But for pharmaceutical corporation Novo Nordisk, Ozempic is a chance to price gouge Americans hand over fist.

The Senate Health, Education, Labor and Pensions (HELP) Committee is calling on Novo Nordisk to lower the unreasonably high prices Americans are being forced to pay for the diabetes drug Ozempic and the related weight-loss drug Wegovy.

Tomorrow, the CEO of Novo Nordisk is testifying in front of the Senate HELP Committee. Before he testifies, join us in demanding that Novo Nordisk immediately lower the price of Ozempic and Wegovy.

Novo Nordisk must lower the price of Ozempic and Wegovy TODAY!